Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | December 29, 2022 09:07am

Gainers

  • Quotient (NASDAQ:QTNT) stock moved upwards by 114.0% to $0.49 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 million.
  • Baudax Bio (NASDAQ:BXRX) shares increased by 84.34% to $4.24. The market value of their outstanding shares is at $2.3 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) shares increased by 49.19% to $18.62. The market value of their outstanding shares is at $29.7 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 27.85% to $0.78. The company's market cap stands at $10.1 million.
  • Journey Medical (NASDAQ:DERM) shares increased by 20.33% to $1.42. The company's market cap stands at $25.1 million.
  • Nuwellis (NASDAQ:NUWE) stock rose 19.95% to $11.0. The company's market cap stands at $3.4 million.

Losers

  • Exicure (NASDAQ:XCUR) shares fell 11.2% to $1.03 during Thursday's pre-market session. The company's market cap stands at $5.1 million.
  • Vaxxinity (NASDAQ:VAXX) shares declined by 7.98% to $1.27. The market value of their outstanding shares is at $160.0 million.
  • Codex DNA (NASDAQ:DNAY) shares decreased by 7.44% to $1.12. The company's market cap stands at $33.0 million.
  • Unicycive Therapeutics (NASDAQ:UNCY) shares fell 7.0% to $0.47. The company's market cap stands at $7.0 million.
  • Relmada Therapeutics (NASDAQ:RLMD) stock decreased by 6.26% to $3.0. The market value of their outstanding shares is at $90.2 million.
  • Black Diamond Therapeutic (NASDAQ:BDTX) stock decreased by 6.19% to $1.54. The company's market cap stands at $55.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BDTX BXRX DERM DNAY KALA NUWE QTNT RLMD RNAZ UNCY VAXX XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist